Lupus drug may save fertility: survey launched
NCT ID NCT05567198
First seen Apr 09, 2026 · Last updated May 12, 2026 · Updated 6 times
Summary
This study surveys 100 women under 40 with lupus who received a chemotherapy-like drug called cyclophosphamide. Some also got a hormone drug (GnRHa) to protect their ovaries. Researchers want to see if GnRHa helps prevent early menopause and infertility. No new treatments are given; participants fill out a one-time survey about their periods and pregnancy history.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
RECRUITINGBethesda, Maryland, 20892, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.